Dexlansoprazole Capsule, Delayed Release
Product Images NDC 50090-5944

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 50090-5944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dexlansoprazole 01)

Chemical structure of dexlansoprazole, the active ingredient in Dexlansoprazole delayed release 60 mg capsules by A-S Medication Solutions.*

FDA Label Image

Figure 1 (Dexlansoprazole 02)

A line graph showing plasma concentration (ng/mL) of dexlansoprazole over time (hours) for 30 mg and 60 mg doses. The 60 mg dose shows higher plasma concentrations peaking around 4 hours, while the 30 mg dose shows lower concentrations with an earlier peak. Both doses decline towards zero by 24 hours.*

FDA Label Image

Label Image (Lbl500905944)

Dexlansoprazole delayed release 60 mg capsules label from A-S Medication Solutions. The label includes product NDC 50090-5944-0 and storage instructions to keep at 68 to 77 degrees Fahrenheit. It states each blue capsule contains 60 mg of dexlansoprazole as enteric-coated granules. The package contains 30 delayed-release capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.